Biogen, Inc. (BIIB)
250.69
-3.15
(-1.24%)
USD |
NASDAQ |
Oct 23, 16:00
247.18
-3.51
(-1.40%)
After-Hours: 20:00
Biogen Total Return Level : 250.69 for Oct. 23, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 23, 2026 | 250.69 |
| October 22, 2026 | 253.84 |
| October 21, 2026 | 240.98 |
| October 20, 2026 | 243.10 |
| October 19, 2026 | 233.48 |
| October 16, 2026 | 232.65 |
| October 15, 2026 | 235.35 |
| October 14, 2026 | 232.83 |
| October 13, 2026 | 228.90 |
| October 12, 2026 | 229.41 |
| October 09, 2026 | 225.71 |
| October 08, 2026 | 218.43 |
| October 07, 2026 | 222.15 |
| October 06, 2026 | 222.89 |
| October 05, 2026 | 223.59 |
| October 02, 2026 | 219.88 |
| October 01, 2026 | 222.82 |
| September 30, 2026 | 225.88 |
| September 29, 2026 | 227.07 |
| September 28, 2026 | 228.69 |
| September 25, 2026 | 227.60 |
| September 24, 2026 | 226.36 |
| September 23, 2026 | 227.53 |
| September 22, 2026 | 225.36 |
| September 21, 2026 | 219.07 |
| Date | Value |
|---|---|
| September 18, 2026 | 215.50 |
| September 17, 2026 | 219.05 |
| September 16, 2026 | 216.01 |
| September 15, 2026 | 216.17 |
| September 14, 2026 | 217.36 |
| September 11, 2026 | 217.15 |
| September 10, 2026 | 215.43 |
| September 09, 2026 | 210.73 |
| September 08, 2026 | 212.50 |
| September 04, 2026 | 220.83 |
| September 03, 2026 | 224.51 |
| September 02, 2026 | 222.67 |
| September 01, 2026 | 216.04 |
| August 31, 2026 | 216.65 |
| August 28, 2026 | 218.50 |
| August 27, 2026 | 221.50 |
| August 26, 2026 | 221.07 |
| August 25, 2026 | 220.77 |
| August 24, 2026 | 218.12 |
| August 21, 2026 | 216.78 |
| August 20, 2026 | 214.35 |
| August 19, 2026 | 221.56 |
| August 18, 2026 | 212.55 |
| August 17, 2026 | 209.15 |
| August 14, 2026 | 209.83 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| AbbVie, Inc. | 495.02 |
| Gilead Sciences, Inc. | 228.69 |
| Amgen, Inc. | 657.76 |
| Ionis Pharmaceuticals, Inc. | 42.93 |
| Regeneron Pharmaceuticals, Inc. | 812.48 |